CLL B-cells were treated with a combination of PMA and IL-4 to test for any cumulative effect on survival (Figure 3F): the effect of this combination on CLL B-cells survival was no greater than either of the individual effects. This evidence concerns the gene IL4 and B-cell chronic lymphocytic leukemia.